News impact
QURE· last 90 days
UNIQURE NV
Backward-looking only. These statistics describe how the price moved after past news — nothing more. Sample sizes are small, market context differs every day, and past performance is not indicative of future results. See methodology and disclaimer.
Bullish news (sentiment ≥ 0.3)
1articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Neutral news (−0.3 to 0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Bearish news (sentiment ≤ −0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Per-event price reaction · 1 events
- CNBC6/17/2026, 4:12:05 PMUniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agencySentiment0.30Relevance100%+24h—+72h—+7d—
Not investment advice. See full disclaimer.